UB Paderborn / Katalog / Suche / in CDI

Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator

Circulation (New York, N.Y.), 2013-08, Vol.128 (9), p.944-953

2013

Link zum Volltext

Verfügbarkeit prüfen

Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication

Heart rhythm, 2017-03, Vol.14 (3), p.367-375

2017

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Different Device-Based Intrathoracic Impedance Vectors for Detection of Heart Failure Events (from the Detect Fluid Early from Intrathoracic Impedance Monitoring Study)

The American journal of cardiology, 2014-10, Vol.114 (8), p.1249-1256

2014

Link zum Volltext

Verfügbarkeit prüfen

Heart transplant medicine: Beyond the guidelines

The Journal of heart and lung transplantation, 2013-12, Vol.32 (12), p.1170-1171

Herre, John M., MD

2013

Link zum Volltext

Verfügbarkeit prüfen

Minocycline-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome with persistent myocarditis

Journal of the American Academy of Dermatology, 2010-02, Vol.62 (2), p.315-318

2010

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry

Journal of the American College of Cardiology, 2015-04, Vol.65 (16), p.1605-1615

2015

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator

Journal of the American College of Cardiology, 2015-04, Vol.65 (16), p.1605-1615

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes of ventricular assist device support by HIV infection status: An STS-INTERMACS analysis

The Journal of heart and lung transplantation, 2023-09, Vol.42 (9), p.1185-1193

2023

Link zum Volltext

Verfügbarkeit prüfen

Abnormal Conduction Increases Risk of Adverse Outcomes From Right Ventricular Pacing

Journal of the American College of Cardiology, 2006-10, Vol.48 (8), p.1628-1633

2006

Link zum Volltext

Verfügbarkeit prüfen

Cardiac Resynchronization Induces Major Structural and Functional Reverse Remodeling in Patients With New York Heart Association Class I/II Heart Failure

Circulation (New York, N.Y.), 2009-11, Vol.120 (19), p.1858-1865

2009

Link zum Volltext

Verfügbarkeit prüfen

Intoxicated Donors and Heart Transplant Outcomes: Long-Term Safety

Circulation. Heart failure, 2021-08, Vol.14 (8), p.e007433-e007433

2021

Link zum Volltext

Verfügbarkeit prüfen

Gastrointestinal Bleeding Rates in Left Ventricular Assist Device Population Reduced with Octreotide Utilization

ASAIO journal (1992), 2021-09, Vol.67 (9), p.989-994

2021

Link zum Volltext

Verfügbarkeit prüfen

Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipients

Transplant immunology, 2022-12, Vol.75, p.101722-101722, Article 101722

2022

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of subcutaneous implantable cardioverter-defibrillator in dialysis patients: Results from the S-ICD post-approval study

Heart rhythm, 2020-09, Vol.17 (9), p.1566-1574

2020

Link zum Volltext

Verfügbarkeit prüfen

The utilization and safety of apixaban for therapeutic anticoagulation in heart transplant population requiring routine endomyocardial biopsies

Clinical transplantation, 2022-12, Vol.36 (12), p.e14828-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Protocol-based anticoagulation management for mechanical circulatory support patients can be safe and efficient

International journal of artificial organs, 2022-06, Vol.45 (6), p.564-570

2022

Link zum Volltext

Verfügbarkeit prüfen

Accurate monitoring of intravascular fluid volume: A novel application of intrathoracic impedance measures for the guidance of volume reduction therapy

International journal of cardiology. Heart & vasculature, 2015-09, Vol.8 (C), p.47-51

2015

Link zum Volltext

Verfügbarkeit prüfen

Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure: A Substudy of the TRANSFORM-HF Randomized Clinical Trial

JAMA cardiology, 2024-02, Vol.9 (2), p.182

2024

Link zum Volltext

Verfügbarkeit prüfen

Heart rate, pacing, and outcome in the Dual Chamber and VVI Implantable Defibrillator (DAVID) trials

Heart rhythm, 2009-08, Vol.6 (8), p.1129-1135

2009

Link zum Volltext

Verfügbarkeit prüfen

Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure

Circulation. Heart failure, 2013-11, Vol.6 (6), p.1180-1189

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical Performance of the St. Jude Medical Riata Defibrillation Lead in a Large Patient Population

Journal of cardiovascular electrophysiology, 2010-05, Vol.21 (5), p.551-556

2010

Link zum Volltext

Verfügbarkeit prüfen

The effect of left ventricular pacing site on cardiac resynchronization therapy outcome and mortality: the results of a PROSPECT substudy

Europace (London, England), 2010-12, Vol.12 (12), p.1750-1756

2010

Link zum Volltext

Verfügbarkeit prüfen

Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation

Circulation (New York, N.Y.), 1995-12, Vol.92 (11), p.3255-3263

1995

Link zum Volltext

Verfügbarkeit prüfen

Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2023-01, Vol.329 (3), p.214

2023

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of a Subcutaneous Implantable-Defibrillator

Heart rhythm, 2012-09, Vol.9 (9), p.1579-1580

2012

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator

Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication

Analysis of Different Device-Based Intrathoracic Impedance Vectors for Detection of Heart Failure Events (from the Detect Fluid Early from Intrathoracic Impedance Monitoring Study)

Heart transplant medicine: Beyond the guidelines

Minocycline-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome with persistent myocarditis

Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry

Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator

Clinical outcomes of ventricular assist device support by HIV infection status: An STS-INTERMACS analysis

Abnormal Conduction Increases Risk of Adverse Outcomes From Right Ventricular Pacing

Cardiac Resynchronization Induces Major Structural and Functional Reverse Remodeling in Patients With New York Heart Association Class I/II Heart Failure

Intoxicated Donors and Heart Transplant Outcomes: Long-Term Safety

Gastrointestinal Bleeding Rates in Left Ventricular Assist Device Population Reduced with Octreotide Utilization

Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipients

Outcomes of subcutaneous implantable cardioverter-defibrillator in dialysis patients: Results from the S-ICD post-approval study

The utilization and safety of apixaban for therapeutic anticoagulation in heart transplant population requiring routine endomyocardial biopsies

Protocol-based anticoagulation management for mechanical circulatory support patients can be safe and efficient

Accurate monitoring of intravascular fluid volume: A novel application of intrathoracic impedance measures for the guidance of volume reduction therapy

Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure: A Substudy of the TRANSFORM-HF Randomized Clinical Trial

Heart rate, pacing, and outcome in the Dual Chamber and VVI Implantable Defibrillator (DAVID) trials

Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure

Clinical Performance of the St. Jude Medical Riata Defibrillation Lead in a Large Patient Population

The effect of left ventricular pacing site on cardiac resynchronization therapy outcome and mortality: the results of a PROSPECT substudy

Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation

Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial

Safety and Efficacy of a Subcutaneous Implantable-Defibrillator

Suchergebnisse filtern